HRP20120135T1 - Derivati stirilpiridina i njihova upotreba kod vezanja na i vizualizacije amiloidnih plakova - Google Patents

Derivati stirilpiridina i njihova upotreba kod vezanja na i vizualizacije amiloidnih plakova Download PDF

Info

Publication number
HRP20120135T1
HRP20120135T1 HR20120135T HRP20120135T HRP20120135T1 HR P20120135 T1 HRP20120135 T1 HR P20120135T1 HR 20120135 T HR20120135 T HR 20120135T HR P20120135 T HRP20120135 T HR P20120135T HR P20120135 T1 HRP20120135 T1 HR P20120135T1
Authority
HR
Croatia
Prior art keywords
halogen substituted
image
halogen
compound according
formula
Prior art date
Application number
HR20120135T
Other languages
English (en)
Croatian (hr)
Inventor
F. Kung Hank
Kung Mei-Ping
Original Assignee
The Trustees Of The University Of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of The University Of Pennsylvania filed Critical The Trustees Of The University Of Pennsylvania
Publication of HRP20120135T1 publication Critical patent/HRP20120135T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20120135T 2006-03-30 2007-03-26 Derivati stirilpiridina i njihova upotreba kod vezanja na i vizualizacije amiloidnih plakova HRP20120135T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78715606P 2006-03-30 2006-03-30
PCT/US2007/007400 WO2007126733A2 (en) 2006-03-30 2007-03-26 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques

Publications (1)

Publication Number Publication Date
HRP20120135T1 true HRP20120135T1 (hr) 2012-03-31

Family

ID=38326579

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20120135T HRP20120135T1 (hr) 2006-03-30 2007-03-26 Derivati stirilpiridina i njihova upotreba kod vezanja na i vizualizacije amiloidnih plakova
HRP20170857TT HRP20170857T1 (hr) 2006-03-30 2017-06-06 Derivati stirilpiridina i njihova uporaba za vezanje i snimanje amiloidnih naslaga

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20170857TT HRP20170857T1 (hr) 2006-03-30 2017-06-06 Derivati stirilpiridina i njihova uporaba za vezanje i snimanje amiloidnih naslaga

Country Status (35)

Country Link
US (3) US7687052B2 (enExample)
EP (3) EP2363392B1 (enExample)
JP (1) JP5290954B2 (enExample)
KR (1) KR101376807B1 (enExample)
CN (1) CN101522624B (enExample)
AT (1) ATE539060T1 (enExample)
AU (1) AU2007243712B2 (enExample)
BE (1) BE2013C044I2 (enExample)
BR (1) BRPI0710225B1 (enExample)
CA (1) CA2644530C (enExample)
CR (1) CR10329A (enExample)
CY (3) CY1113048T1 (enExample)
DK (2) DK2363392T3 (enExample)
EA (1) EA017898B1 (enExample)
EC (1) ECSP088783A (enExample)
ES (2) ES2628882T3 (enExample)
FR (1) FR13C0034I2 (enExample)
GT (1) GT200800201A (enExample)
HR (2) HRP20120135T1 (enExample)
HU (2) HUE032660T2 (enExample)
IL (1) IL193567A (enExample)
LT (1) LT2363392T (enExample)
LU (1) LU92232I2 (enExample)
MX (1) MX2008012527A (enExample)
NO (2) NO342090B1 (enExample)
NZ (1) NZ570887A (enExample)
PL (2) PL1999109T3 (enExample)
PT (2) PT2363392T (enExample)
RS (2) RS56171B1 (enExample)
SG (1) SG173338A1 (enExample)
SI (2) SI2363392T1 (enExample)
TW (1) TWI399366B (enExample)
UA (1) UA97802C2 (enExample)
WO (1) WO2007126733A2 (enExample)
ZA (1) ZA200807955B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1999109T3 (pl) 2006-03-30 2012-05-31 Univ Pennsylvania Pochodne styrylopirydyny i ich zastosowanie do wiązania i obrazowania blaszek amyloidowych
CA2699965A1 (en) * 2007-07-04 2009-01-08 Tohoku University Pet probe having an alkoxy group substituted by fluorine and hydroxy group
US8557222B2 (en) * 2008-04-04 2013-10-15 Avid Radiopharmaceuticals, Inc. Radiopharmaceutical imaging of neurodegenerative diseases
AU2009335049B2 (en) * 2008-12-31 2015-07-16 Avid Radiopharmaceuticals, Inc. Synthesis of 18F-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
US8968701B2 (en) * 2009-07-10 2015-03-03 Piramal Imaging Sa Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
US20120263646A1 (en) 2009-10-15 2012-10-18 Guerbet Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
AU2010334929B2 (en) * 2009-12-23 2015-04-23 Lantheus Biosciences Ltd. Formulations suitable for pet imaging with hydrophobic pet agents
WO2011141515A1 (en) 2010-05-14 2011-11-17 Bayer Pharma Aktiengesellschaft Diagnostic agents for amyloid beta imaging
CA2801530C (en) 2010-06-04 2017-09-12 Piramal Imaging Sa Method for production of f-18 labeled amyloid beta ligands
BR112012030946A2 (pt) * 2010-06-04 2016-11-01 Piramal Imaging Sa método para a produção de ligante para amiloide beta marcado com f-18
EA201201647A1 (ru) * 2010-06-04 2013-05-30 Пирамаль Имэджинг Са Способ получения f-18 меченных лигандов бета-амилоида
TWI504414B (zh) 2010-06-04 2015-10-21 Bayer Schering Pharma Ag 生產Ｆ－１８標記之Ａβ配位體之方法
CN101891674B (zh) * 2010-06-24 2012-11-14 山东大学 4-苯乙烯基吡啶类化合物及其制备方法与应用
EP3263136A1 (en) * 2010-10-12 2018-01-03 Mayo Foundation for Medical Education and Research Imaging of meningiomas using stilbene, or biphenylalkyne derivatives
US20140079635A1 (en) * 2011-03-30 2014-03-20 Case Western Reserve University Molecular probes for detecting lipid composition
WO2012145169A2 (en) 2011-04-21 2012-10-26 The Regents Of The University Of California Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
CA2852840A1 (en) 2011-10-19 2013-04-25 Piramal Imaging Sa Improved method for production of f-18 labeled a.beta. ligands
CA2869398C (en) 2012-04-10 2019-10-22 Lantheus Medical Imaging, Inc. Radiopharmaceutical synthesis methods
JP6099045B2 (ja) * 2013-04-30 2017-03-22 国立大学法人京都大学 トリアゾロピリミジン誘導体化合物
JP2014218454A (ja) * 2013-05-07 2014-11-20 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
JP6041751B2 (ja) * 2013-05-07 2016-12-14 日本メジフィジックス株式会社 スチリルピリジン誘導体化合物
CN103645254B (zh) * 2013-11-28 2015-01-07 江苏省原子医学研究所 一种Aβ斑块显像剂前体AV45的含量分析方法
MX376163B (es) * 2014-05-13 2025-03-07 Hoffmann La Roche Compuestos heterocíclicos deuterados y su uso como agentes formadores de imágenes.
JP7114074B2 (ja) * 2015-08-18 2022-08-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 画像化のためのニトロキシドを含むアミロイド結合剤およびその治療的使用
US10300155B2 (en) 2015-12-31 2019-05-28 Washington University Alpha-synuclein ligands
CN109400615B (zh) * 2017-08-18 2021-07-16 上海交通大学医学院附属新华医院 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
CN108299287A (zh) * 2018-01-02 2018-07-20 北京师范大学 与Aβ斑块具有高亲和力的N2S2类吡啶基苯乙烯化合物
CN114805190A (zh) * 2022-06-08 2022-07-29 吉林大学第一医院 一种甲基苯胺类Aβ蛋白显像剂的双柱合成方法
KR20250107902A (ko) 2022-11-14 2025-07-14 일라이 릴리 앤드 캄파니 플로르베타피르 전구체 av-105의 다형체 형태

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000963A1 (fr) * 1990-07-12 1992-01-23 Yoshitomi Pharmaceutical Industries, Ltd. Composes de styryle et leur utilisation comme medicaments
JPH0545875A (ja) * 1991-08-08 1993-02-26 Konica Corp 感光性組成物
US6020436A (en) * 1993-03-09 2000-02-01 The Chromaline Corporation Photosensitive resin composition
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
EP1266884A4 (en) * 2000-03-22 2003-04-23 Bf Res Inst Inc IMAGE DIAGNOSIS PROBE, BASED ON SUBSTITUTED AZOBENZOL OR ITS ANALOGA, FOR DISEASES WHICH ARE ATTRIBUTED TO AMYLOID ACCUMULATION, AND MIXTURES CONTAINING THIS IMAGE
US8007954B2 (en) 2000-11-09 2011-08-30 The Trustees Of The University Of Pennsylvania Use of sulfur-containing fuels for direct oxidation fuel cells
JP2002182254A (ja) 2000-12-18 2002-06-26 Fuji Photo Film Co Ltd 非線形光学材料とその製造方法
AU2002323417B2 (en) * 2001-08-27 2008-05-15 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
EP1530814A4 (en) 2002-06-06 2009-05-27 Univ Pennsylvania CERAMIC ANODES AND PROCESS FOR PRODUCING THESE ANODES
WO2004016271A1 (en) * 2002-08-14 2004-02-26 Axxima Pharmaceuticals Ag Pyrimidones as antiviral agents
JP4482352B2 (ja) 2004-03-11 2010-06-16 本田技研工業株式会社 固体高分子型燃料電池
WO2006078384A2 (en) * 2004-12-17 2006-07-27 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use
CA2591534C (en) * 2004-12-17 2013-08-06 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
US20070031328A1 (en) * 2005-06-24 2007-02-08 Kung Hank F Radiolabeled-pegylation of ligands for use as imaging agents
PL1999109T3 (pl) * 2006-03-30 2012-05-31 Univ Pennsylvania Pochodne styrylopirydyny i ich zastosowanie do wiązania i obrazowania blaszek amyloidowych
US20080253967A1 (en) 2007-04-13 2008-10-16 Kung Hank F Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques

Also Published As

Publication number Publication date
LU92232I2 (fr) 2013-08-26
US20080038195A1 (en) 2008-02-14
UA97802C2 (uk) 2012-03-26
RS52222B (sr) 2012-10-31
HRP20170857T1 (hr) 2017-12-01
ES2378785T3 (es) 2012-04-17
IL193567A (en) 2014-03-31
WO2007126733A2 (en) 2007-11-08
WO2007126733A3 (en) 2008-03-06
EP2363392B1 (en) 2017-05-03
SI2363392T1 (sl) 2017-09-29
ZA200807955B (en) 2012-11-28
CY1113048T1 (el) 2015-11-04
JP2009532349A (ja) 2009-09-10
EP2363392A1 (en) 2011-09-07
LT2363392T (lt) 2017-07-25
CY2013024I2 (el) 2015-11-04
FR13C0034I2 (fr) 2014-03-07
SI1999109T1 (sl) 2012-04-30
US8506929B2 (en) 2013-08-13
KR20080106564A (ko) 2008-12-08
CR10329A (es) 2008-10-29
HUE032660T2 (en) 2017-10-30
CA2644530A1 (en) 2007-11-08
EA200870389A1 (ru) 2009-04-28
CY1119048T1 (el) 2018-01-10
DK1999109T3 (da) 2012-04-02
SG173338A1 (en) 2011-08-29
US20090123369A1 (en) 2009-05-14
MX2008012527A (es) 2008-10-14
AU2007243712B2 (en) 2013-01-10
EP2363391A1 (en) 2011-09-07
PL1999109T3 (pl) 2012-05-31
PT2363392T (pt) 2017-06-15
ECSP088783A (es) 2008-10-31
EA017898B1 (ru) 2013-04-30
US8840866B2 (en) 2014-09-23
PL2363392T3 (pl) 2017-10-31
TW200838852A (en) 2008-10-01
EP1999109A2 (en) 2008-12-10
BE2013C044I2 (enExample) 2026-04-24
EP1999109B1 (en) 2011-12-28
NO2018030I1 (no) 2018-09-11
TWI399366B (zh) 2013-06-21
CN101522624B (zh) 2013-11-06
ES2628882T3 (es) 2017-08-04
KR101376807B1 (ko) 2014-03-20
GT200800201A (es) 2009-08-20
AU2007243712A1 (en) 2007-11-08
CA2644530C (en) 2015-05-19
US7687052B2 (en) 2010-03-30
NO20084590L (no) 2008-12-29
NO342090B1 (no) 2018-03-19
FR13C0034I1 (enExample) 2013-08-09
DK2363392T3 (en) 2017-07-03
BRPI0710225B1 (pt) 2021-07-13
NZ570887A (en) 2011-05-27
BRPI0710225A2 (pt) 2011-08-02
ATE539060T1 (de) 2012-01-15
CY2013024I1 (el) 2015-11-04
HUS1300028I1 (hu) 2017-08-28
PT1999109E (pt) 2012-03-16
US20130129624A1 (en) 2013-05-23
CN101522624A (zh) 2009-09-02
IL193567A0 (en) 2009-05-04
LU92232I9 (enExample) 2019-01-15
JP5290954B2 (ja) 2013-09-18
RS56171B1 (sr) 2017-11-30

Similar Documents

Publication Publication Date Title
RU2008150377A (ru) Новое соединение, обладающее сродством к амилоиду
SI2004155T1 (en) Inhibitors of protein aggregation
RU2008147002A (ru) Новые соединения, обладающие сродством к амилоиду
HRP20210726T1 (hr) Ciklički dinukleotidi kao antagonisti sting (stimulatora interferonskih gena)
MX367292B (es) Ligandos para formacion de imagen de inervacion cardiaca.
HRP20170857T1 (hr) Derivati stirilpiridina i njihova uporaba za vezanje i snimanje amiloidnih naslaga
JP2016506935A5 (enExample)
MX375556B (es) Compuestos de benzoxaborol tricíclicos y usos de los mismos.
HRP20161103T1 (hr) Kemijski spojevi
EP2215834A4 (en) CMOS SENSOR DESIGNED FOR DENTAL X-RAY IMAGING
HRP20161163T1 (hr) Postupak priprave 6-(7-((1-aminociklopropil)metoksi)-6-metoksikinolin-4-iloksi)-n-metil-1-naftamida i njegovih sintetičkih međuprodukata
RU2016118399A (ru) Производные 4-аминометилбензойной кислоты
AR068897A1 (es) Inhibidores de proteasoma
AR071054A1 (es) Compuestos para usar en la formacion de imagenes el diagnostico y/o el tratamiento de enfermedades del sistema nervioso central o de tumores, metodos de preparacion, composiciones farmaceuticas, usos y metodos de deteccion de monoamina oxidasa.
AR077054A1 (es) Derivados de benzimidazol utiles como moduladores del canal trpm8
HRP20160523T1 (hr) Antikancerozni steroidni laktoni, nezasićeni na položaju 7(8)
AR064136A1 (es) Derivados de espiro-piperidina, metodos para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades relacionadas con la accion antagonista del receptor v1a.
RU2020119562A (ru) Хиназолиноновое соединение и его применение
SV2009003205A (es) Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet)
AR033680A1 (es) Compuestos triciclicos utiles como inhibidores de la farnesil proteino transferasa y su uso para la manufactura de medicamentos como agentes antitumorales
AR039557A1 (es) Inhibidores novedosos de la farnesil proteina transferasa como agentes antitumorales
EP2374479A4 (en) COMPOSITION WITH CONTROLLED RELEASE FOR PRODUCING UDENAFIL-CONTAINING PREPARATION WITH DELAYED RELEASE
AR088909A1 (es) Compuestos de hidrocarburos aromaticos policiclicos que contienen un atomo de s o un grupo s(=o)₂ en su estructura basica
EP2929786A4 (en) COMPOSITION WITH NATURAL POLYPHENOL COMPOUNDS AND COMPOSITION FOR ORAL ADMINISTRATION THEREWITH
HRP20201217T1 (hr) Derivati di(fenilpropanoid)glicerola za liječenje raka